Last updated: 29 August 2024 at 4:46pm EST

Tate Deborah Taylor Net Worth




The estimated Net Worth of Tate Deborah Taylor is at least $1.08 millió dollars as of 29 August 2024. Tate Taylor owns over 1,400 units of Healthstream Inc stock worth over $623,119 and over the last 14 years Tate sold HSTM stock worth over $457,037.

Tate Taylor HSTM stock SEC Form 4 insiders trading

Tate has made over 23 trades of the Healthstream Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Tate sold 1,400 units of HSTM stock worth $39,942 on 29 August 2024.

The largest trade Tate's ever made was exercising 15,000 units of Healthstream Inc stock on 7 March 2018 worth over $183,450. On average, Tate trades about 1,802 units every 104 days since 2010. As of 29 August 2024 Tate still owns at least 22,326 units of Healthstream Inc stock.

You can see the complete history of Tate Taylor stock trades at the bottom of the page.



What's Tate Taylor's mailing address?

Tate's mailing address filed with the SEC is 500 11TH AVENUE NORTH, SUITE 1000, NASHVILLE, TN, 37203.

Insiders trading at Healthstream Inc

Over the last 22 years, insiders at Healthstream Inc have traded over $15,411,269 worth of Healthstream Inc stock and bought 13,500 units worth $333,060 . The most active insiders traders include Arthur E Newman, J Edward Pearson és Michael Sousa. On average, Healthstream Inc executives and independent directors trade stock every 12 days with the average trade being worth of $218,870. The most recent stock trade was executed by Tate Deborah Taylor on 29 August 2024, trading 1,400 units of HSTM stock currently worth $39,942.



What does Healthstream Inc do?

thousands of healthcare providers, including half of u.s. hospitals, have chosen healthstream (nasdaq: hstm) as their partner for improving clinical and business outcomes. in this new era of healthcare reform, meaningful use, and value-based purchasing, hundreds of leading organizations each year are switching to healthstream to elevate the role of learning and development in addressing these challenges. our vision healthstream’s vision is to improve the quality of healthcare by assessing and developing the people who deliver care.



Complete history of Tate Taylor stock trades at Healthstream Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Tate Deborah Taylor
Rendező
Eladás $39,942
29 Aug 2024
Tate Deborah Taylor
Rendező
Opció Gyakorlat $31,646
6 Jun 2024
Tate Deborah Taylor
Rendező
Opció Gyakorlat $54,518
25 Mar 2024
Tate Deborah Taylor
Rendező
Opció Gyakorlat $79,266
23 Mar 2023
Tate Deborah Taylor
Rendező
Eladás $85,227
24 Feb 2023
Tate Deborah Taylor
Rendező
Opció Gyakorlat $54,757
17 Mar 2022
Tate Deborah Taylor
Rendező
Eladás $30,350
16 Aug 2021
Tate Deborah Taylor
Rendező
Opció Gyakorlat $60,369
16 Mar 2021
Tate Deborah Taylor
Rendező
Opció Gyakorlat $57,612
17 Mar 2020
Tate Deborah Taylor
Rendező
Eladás $183,744
31 Oct 2019
Tate Deborah Taylor
Rendező
Opció Gyakorlat $79,351
15 Mar 2019
Tate Deborah Taylor
Rendező
Opció Gyakorlat $69,898
19 Mar 2018
Tate Deborah Taylor
Rendező
Opció Gyakorlat $183,450
7 Mar 2018
Tate Deborah Taylor
Rendező
Opció Gyakorlat $61,951
20 Mar 2017
Tate Deborah Taylor
Rendező
Eladás $36,420
15 Aug 2016
Tate Deborah Taylor
Rendező
Opció Gyakorlat $52,379
17 Mar 2016
Tate Deborah Taylor
Rendező
Opció Gyakorlat $52,379
17 Mar 2016
Tate Deborah Taylor
Rendező
Opció Gyakorlat $71,370
18 Mar 2015
Tate Deborah Taylor
Rendező
Opció Gyakorlat $22,463
13 Aug 2014
Tate Deborah Taylor
Rendező
Opció Gyakorlat $61,540
18 Mar 2014
Tate Deborah Taylor
Rendező
Opció Gyakorlat $21,340
21 Mar 2013
Tate Deborah Taylor
Rendező
Eladás $81,354
11 Mar 2013
Tate Deborah Taylor
Rendező
Opció Gyakorlat $23,960
7 Dec 2012


Healthstream Inc executives and stock owners

Healthstream Inc executives and other stock owners filed with the SEC include: